Psoriasis

Psoriasis is a chronic, non-contagious skin disease that affects approximately 2% of the population. Considerable progress has been made over the past decade to further understanding of the causes of psoriasis, leading to more effective treatment options.

Psoriasis research at The University of Manchester is widely regarded as one of the most comprehensive research programmes in the world. Research is intimately associated with the Psoriasis clinic at Salford Royal NHS Foundation Trust, founded in 1994 by Professor Griffiths and Dr Robert Chalmers.

Current work

Our academic studies aim to increase our understanding of psoriasis. Current investigations include a study aiming to distinguish the different types of psoriasis, and a study exploring individual treatment responses.

We also conduct clinical trials to test the effectiveness of new drugs in the treatment of psoriasis.

BADBIR

Salford Royal NHS Foundation Trust is an active recruitment centre for The British Association of Dermatologists Biologic Interventions Register (BADBIR). This is a national register of all patients receiving biologic therapy for the treatment of psoriasis in the UK. The primary aim of the register is to monitor the safety of these drugs. Professor Griffiths is the principle investigator for BADBIR, which is based at The University of Manchester's URC Epidemiology Unit.

Find out more: BADBIR

IMPACT

Professor Griffiths is also the principal investigator for the IMPACT (Identification and Management of Psoriasis Associated ComorbidiTy) programme of research. Awarded a £2 million National Institute for Health Research grant, the project will last 5 years and aims to improve the care of people with psoriasis.

Find out more: IMPACT study

The University of Manchester is not responsible for the content of external internet sites.